Emergence of COVID-19 Expected To Boost Growth of India & Oman Pharmaceutical Industry
India & Oman Pharmaceutical Industry discovers, develops, and markets pharmaceutical drugs to treat patients, with the aim to cure them or alleviate the symptoms. Indian pharmaceutical industry is the world's largest provider of generic medicines. According to India Brand Equity Foundation (IBEF), Indian pharmaceutical industry supplies over 50% of global demand for various vaccines, 25% of all medicine in the United Kingdom, and 40% of generic demand in the United States. Worldwide, India ranks 3rd in terms of pharmaceutical production by volume and 14th by value.
Moreover, India & Oman Pharmaceutical Industry produces drugs used to treat various life-threatening diseases, such as cardiovascular disease, cancer, diabetes, chronic kidney diseases, and others. Thus, with the increasing prevalence of aforementioned disease, the demand for safe and effective pharmaceuticals is also increasing in India and Oman. According to the latest WHO (World Health Organization) data published in 2018, coronary heart disease deaths in Oman reached 2,904 or 28.23% of total deaths. Chronic kidney disease (CKD) is the sixth main cause of death in Oman.
Comments
Post a Comment